Aptamer Group (LSE:APTA) Retained Earnings : £-12.94 Mil (As of Jun. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Aptamer Group Retained Earnings?

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. Aptamer Group's retained earnings for the quarter that ended in Jun. 2024 was £-12.94 Mil.

Aptamer Group's quarterly retained earnings declined from Jun. 2023 (£-10.07 Mil) to Dec. 2023 (£-11.79 Mil) and declined from Dec. 2023 (£-11.79 Mil) to Jun. 2024 (£-12.94 Mil).

Aptamer Group's annual retained earnings declined from Jun. 2022 (£-2.31 Mil) to Jun. 2023 (£-10.07 Mil) and declined from Jun. 2023 (£-10.07 Mil) to Jun. 2024 (£-12.94 Mil).

Aptamer Group Retained Earnings Historical Data

The historical data trend for Aptamer Group's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aptamer Group Retained Earnings Chart

Aptamer Group Annual Data

Trend

Mar19

Mar20

Jun22

Jun23

Jun24

Retained Earnings

-2.41

-3.09

-2.31

-10.07

-12.94

Aptamer Group Semi-Annual Data
	Mar19	Mar20	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Retained Earnings	Get a 7-Day Free Trial			-2.31	-4.94	-10.07	-11.79	-12.94

Aptamer Group Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.

Aptamer Group (LSE:APTA) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.

Aptamer Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aptamer Group PLC (LSE:APTA) » Definitions » Retained Earnings

Comparable Companies

Traded in Other Exchanges

N/A

Address

Innovation Way, Windmill House, York, GBR, YO10 5BR

Website

https://www.aptamergroup.com

Aptamer Group PLC provides Optimer binders for use in research, diagnostics and therapeutics. It strives to deliver transformational solutions that meet the needs of researchers and developers across the life sciences through the use of its proprietary Optimer technology. Its businesses: Aptamer Solutions for custom Optimer development, Aptamer Diagnostics for in-house and collaborative Optimer-based diagnostic development and Aptamer Therapeutics for the development of Optimer-based therapeutics. The Group represents a single operating segment being research and experimental development of biotechnology. It operates in United Kingdom, Europe, USA and other; Geographically earning maximum revenue from USA.

Aptamer Group Headlines

No Headlines